ATE435283T1 - Isolierte, für krebs-assoziierte antigene kodierende nukleinsäuremoleküle, die antigene per se und deren anwendungen - Google Patents

Isolierte, für krebs-assoziierte antigene kodierende nukleinsäuremoleküle, die antigene per se und deren anwendungen

Info

Publication number
ATE435283T1
ATE435283T1 AT00993009T AT00993009T ATE435283T1 AT E435283 T1 ATE435283 T1 AT E435283T1 AT 00993009 T AT00993009 T AT 00993009T AT 00993009 T AT00993009 T AT 00993009T AT E435283 T1 ATE435283 T1 AT E435283T1
Authority
AT
Austria
Prior art keywords
applications
associated antigens
nucleic acid
acid molecules
isolated nucleic
Prior art date
Application number
AT00993009T
Other languages
English (en)
Inventor
Dirk Jager
Elisabeth Stockert
Matthew Scanlan
Alexander Knuth
Lloyd Old
Ali Gure
Yao-Tseng Chen
Elke Jaeger
Original Assignee
Ludwig Inst Cancer Res
Sloan Kettering Inst Cancer
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res, Sloan Kettering Inst Cancer, Cornell Res Foundation Inc filed Critical Ludwig Inst Cancer Res
Priority claimed from PCT/US2000/042334 external-priority patent/WO2001047959A2/en
Application granted granted Critical
Publication of ATE435283T1 publication Critical patent/ATE435283T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00993009T 1999-11-30 2000-11-29 Isolierte, für krebs-assoziierte antigene kodierende nukleinsäuremoleküle, die antigene per se und deren anwendungen ATE435283T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/451,739 US6774226B1 (en) 1999-11-30 1999-11-30 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
US09/602,362 US6911529B1 (en) 1999-11-30 2000-06-22 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
PCT/US2000/042334 WO2001047959A2 (en) 1999-11-30 2000-11-29 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

Publications (1)

Publication Number Publication Date
ATE435283T1 true ATE435283T1 (de) 2009-07-15

Family

ID=32825435

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00993009T ATE435283T1 (de) 1999-11-30 2000-11-29 Isolierte, für krebs-assoziierte antigene kodierende nukleinsäuremoleküle, die antigene per se und deren anwendungen

Country Status (3)

Country Link
US (5) US6774226B1 (de)
AT (1) ATE435283T1 (de)
DE (1) DE60042497D1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US7238471B1 (en) * 1999-11-23 2007-07-03 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating breast cancer
US6797471B2 (en) * 2000-08-04 2004-09-28 Board Of Regents, The University Of Texas System Detection and diagnosis of smoking related cancers
WO2002086071A2 (en) * 2001-04-20 2002-10-31 Ludwig Institute For Cancer Research Cancer-testis antigens
WO2003050268A2 (en) * 2001-12-12 2003-06-19 Aventis Pasteur Limited Enhancement of the immune response using cd36-binding domain
EP1615661A2 (de) * 2003-04-15 2006-01-18 Sanofi Pasteur Limited Tumor antigen bfa5 zur prävention und/oder behandlung von krebs
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer
EP1989329A2 (de) * 2006-01-25 2008-11-12 Board of Regents, The University of Texas System Erkennung und diagnose von durch rauchen bedingten krebserkrankungen
KR101932027B1 (ko) * 2007-10-08 2018-12-24 인트렉손 코포레이션 가공된 수지상 세포 및 암의 치료를 위한 이의 용도
EP2224954B1 (de) 2007-11-07 2014-01-08 Celldex Therapeutics, Inc. Menschliche dendritische und epithelzellen 205 (dec-205) bindende antikörper
MX339621B (es) 2010-04-13 2016-06-02 Celldex Therapeutics Inc * Anticuerpos que se unen a cd27 humano y uso de los mismos.
JP6449338B2 (ja) 2014-06-06 2019-01-09 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ グルココルチコイド誘導腫瘍壊死因子受容体（ｇｉｔｒ）に対する抗体およびその使用
UY36687A (es) 2015-05-29 2016-11-30 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware Anticuerpos contra ox40 y sus usos
CN108738324B (zh) 2015-11-19 2022-06-21 百时美施贵宝公司 抗糖皮质激素诱导的肿瘤坏死因子受体(gitr)抗体及其用途
KR102414558B1 (ko) 2016-04-18 2022-06-29 셀덱스 쎄라퓨틱스, 인크. 인간 cd40에 결합하는 효능성 항체 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117633A (en) * 1995-12-08 2000-09-12 University Technologies International Inc. DNA sequence encoding the tumor suppressor gene ING1
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US6255470B1 (en) * 1996-10-03 2001-07-03 Memorial Sloan-Kettering Cancer Center Isolated nucleic acid molecule encoding an esophageal cancer associated antigen
WO1999013079A1 (en) * 1997-09-11 1999-03-18 Beth Israel Deaconess Medical Center Rin2, a novel inhibitor of ras-mediated signaling
AU6289699A (en) * 1998-10-05 2000-04-26 Genzyme Corporation Genes differentially expressed in cancer cells to design cancer vaccines
US6844325B2 (en) * 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6590076B1 (en) * 1999-04-02 2003-07-08 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6518237B1 (en) * 1998-12-28 2003-02-11 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use

Also Published As

Publication number Publication date
US6774226B1 (en) 2004-08-10
US20100278850A1 (en) 2010-11-04
US20080177031A1 (en) 2008-07-24
US6911529B1 (en) 2005-06-28
DE60042497D1 (de) 2009-08-13
US20040126398A1 (en) 2004-07-01
US7622568B2 (en) 2009-11-24
US8071717B2 (en) 2011-12-06

Similar Documents

Publication Publication Date Title
ATE435283T1 (de) Isolierte, für krebs-assoziierte antigene kodierende nukleinsäuremoleküle, die antigene per se und deren anwendungen
WO2001047959A3 (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
MY194997A (en) Anti-ccr7 antibody drug conjugates
DK1601770T3 (da) Streptococcus pyogenes antigener
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
ATE445646T1 (de) Humaner miniantikörper zytotoxisch für tumorzellen die den erbb2 rezeptor exprimieren
DE602006013029D1 (de) Anti-egfr-antikörper
CY1116913T1 (el) Τροποποιημενα κλασματα fab αντισωματων
CY1118949T1 (el) Ανθρωπινα αντισωματα που προσδενουν cxcr4 και χρησεις αυτων
ATE414535T1 (de) Trägerproteine für impfstoffe
TW200510459A (en) RG1 antibodies and uses thereof
UA106036C2 (uk) Анти-мезотелінове антитіло та його застосування
CL2009000575A1 (es) Anticuerpos aislados anti-interleuquina 12 (anti il-12) de mamiferos, secuencia de nucleotidos, vector, celula y metodo de produccion, composicion y dispositivo medico que contienen, util en el diagnostico y tratamiento de condicones relacionadas con il-12.
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
WO2006089230A3 (en) Human monoclonal antibodies to prostate specific membrane antigen (psma)
DE60329489D1 (de) Fusionsproteine humanisierter g250-spezifischer antikörper sowie verwendungen davon
DE69433518D1 (de) Nukleinsäure, die für einen tumor abstossungsantigenvorläufer kodiert
DE60321041D1 (de) Antikörper gegen krebsantigen tmeff2 und seine anwendungen
BRPI0416141B8 (pt) anticorpo anti-cd52 modificado, composição farmacêutica, vetores de expressão, e método para preparar uma imunoglobulina
EP2289907A3 (de) Streptococcus agalactiae-Antigene I + II
WO2003050243A3 (en) Novel genes encoding colon cancer antigens
MX2010001237A (es) Nuevos anticuerpos.
WO2005028498A3 (en) Kid3 and kid3 antibodies that bind thereto
WO2003064593A3 (en) Antigen panels and methods of using the same
MX2024011805A (es) Nuevos anticuerpos anti-fgfr2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1261704

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1261704

Country of ref document: EP